President’s July 2018 highlights and updates
Highlights include JABSOM scholarships, increased research funding, the President's Award for Excellence in Building and Grounds Maintenance and more.
UH Cancer Center celebrates critical national designation
An event commemorated its status as one of only 70 NCI-Designated Cancer Centers across the country.
UH Cancer Center retains national designation
One of only 70 centers acknowledged by the National Cancer Institute, it has also been awarded a $6 million grant from the National Institutes of Health.
UH Cancer Center issues call to action to eliminate HPV-related cancers
The University of Hawaiʻi Cancer Center joins 69 other National Cancer Institute-designated institutions collectively recognizing insufficient vaccination as a public health threat.
Sepsis research wins awards for UH Mānoa graduate student
Natalija Glibetic has earned first-place honors in competitions at the John A. Burns School of Medicine and College of Tropical Agriculture and Human Resources.
UH Cancer Center scientists recognized for international mesothelioma research
Michele Carbone wins the Wagner Medal and Haining Yang earns the research award from the International Mesothelioma Interest Group.
UH Cancer Center’s Hawaiʻi Tumor Registry awarded $1.8 million
The registry has provided incidence and survival data on all cases of cancer in the state since 1973.
3D scanners give new insight to body shape and health
The UH Cancer Center is studying how body shape information can improve health and lengthen lives by using 3D optical scanners and advanced statistical modeling.
New findings on type 2 diabetes and colorectal cancer survival rates
UH researchers Yvette Amshoff, Gertraud Maskarinec and Andrew Grandinetti looked at 24 years of health data and found that patients who have type 2 diabetes in addition to other chronic diseases have a lower survival rate for colorectal cancer.
UH Cancer Center advances research on movement and spread of cancer cells
The research, led by Joe Ramos, may create new opportunities for cancer drug development.
